My

Mycoses

Mycoses is a mycology journal providing an international forum for original papers in English focused on the pathogenesis, diagnosis, therapy, prophylaxis and epidemiology of fungal infectious diseases in humans as well as on the biology of pathogenic fungi. It is of interest to scientists in fundamental mycological research, mycological laboratory diagnosticians and clinicians interested in fungal infections.

Looking to publish in Mycoses? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.

Try Livewrite Now
Subject Dermatology
Impact Factor 3.1
Quartile Q2
Open Access Type Open
ISSN 0933-7407
eISSN 1439-0507
Invitation Only No
Cost Range Article publication charge (APC) applies to accepted and published submissions unless a waiver is applied.

Submission Instructions

Mycoses accepts the following article types. Click on an article type to view submission instructions.

Original Articles

Cover Letter Cover Letter requirements are not specified.
Abstract Abstract is required. Abstract should normally be less than 250 words. Abstract must be structured. Abstract must use the headings Background, Objectives, Patients/Methods, Results, and Conclusions.
Manuscript Manuscript must be divided into Introduction, Materials and methods or patients and methods or subjects and methods for human studies, Results, and Discussion. Manuscript must include eight keywords.
References References may be submitted in any consistent style or format. References must be numbered consecutively in order of appearance and cited in the text using Arabic superscript numerals in consecutive order.
Figures & Tables Figures should be supplied as separate files, while tables may be included in the main text file. Figures and tables must have legends, and table placement and figure position should be indicated in the text.
Reformat to Mycoses using Livewrite Premium

Reviews

Cover Letter Cover Letter requirements are not specified.
Abstract An abstract is required. Abstract should normally be less than 250 words. Abstract does not need to be structured.
Manuscript Manuscript must contain the sections abstract, introduction, methods, results, and conclusions. Main text file must include eight keywords.
References References may be submitted in any consistent style or format. References must be numbered consecutively in order of appearance and cited in the text using Arabic superscript numerals in consecutive order.
Figures & Tables Figures should be supplied as separate files, while tables must be included in the main text file and their placement indicated in the text. Figures and tables must have legends, and tables must be supplied as editable files rather than pasted as images.
Reformat to Mycoses using Livewrite Premium

Recent Publications

Correction to ‘Seroprevalence Screening of Chronic Aspergillus Infection in a Post‐Tuberculosis Cohort in Senegal: A Cross‐Sectional Study Comparing ELISA and Rapid Diagnostic Tests’

-

10.1111/myc.70202
View Publication

Video‐Based Training on Physicians' Proficiency in Invasive Fungal Disease: A Multicentre, Cluster Randomised Controlled Trial

Yijian Chen, Xiaojun Huang, Haibo Qiu, Linling Cheng, Yunsong Yu, Xiaochun Ma, Sizhou Feng, Qi Li, Depei Wu, Wenxiang Huang, Dechang Chen, Xiaoju Lv, Jianda Hu, Jingbo Wang, Jiabin Li, Wenjie Yang, Qingyuan Zhan, Bing Sun, Minggui Wang

10.1111/myc.70198
View Publication

Surgical Outcomes and Exploratory Preoperative Risk Stratification for Invasive Pulmonary Fungal Infections in Paediatric Patients: A Single‐Center Retrospective Study

Gang Yang, Chang Xu, Taozhen He, Xiao‐xi Lu, Xia Guo, Miao Yuan, Yanan Li

10.1111/myc.70201
View Publication

Efficacy Evaluation of Luliconazole‐Loaded Nanostructured Lipid Carriers in Treatment‐Resistant Dermatophytosis: A Randomized Clinical Trial

Robab Ebrahimi Barogh, Seyed Ali Jeddi, Ghasem Rahmatpour Rokni, Hossein Mohammad Taghi Fam, Abbas Raeisabadi, Zahra Yahyazadeh, Seyyed Mobin Rahimnia, Pedram Ebrahimnejad, Eisa Nazar, Nasim Gholizadeh, Iman Haghani, Mohsen Nosratabadi, Armaghan Kazeminejad, Javad Javidnia, Mohammad Taghi Hedayati, Jacques F. Meis, Ahmed Al‐Harrasi, Mahdi Abastabar, Abdullah M. S. Al‐Hatmi

10.1111/myc.70196
View Publication

Issue Information

-

10.1111/myc.70187
View Publication

Frequently asked questions

How long does it take to publish?

Submission to first decision: 6 days (median). Average time to first decision: 12 days including all articles and 34 days excluding articles rejected without peer review.

Reformat to Mycoses using Livewrite Premium

Is a cover letter required?

Cover letters are not mandatory and may be supplied at the author’s discretion; they may be kept short.

Reformat to Mycoses using Livewrite Premium

What are the publication costs?

Article publication charge (APC) applies to accepted and published submissions unless a waiver is applied.

Reformat to Mycoses using Livewrite Premium

Research Topics

Antifungal resistance and susceptibility Nail Diseases and Treatments Fungal Infections and Studies Plant Pathogens and Fungal Diseases Infectious Diseases and Mycology Fungal Plant Pathogen Control Fungal Biology and Applications Yeasts and Rust Fungi Studies Lichen and fungal ecology Pneumocystis jirovecii pneumonia detection and treatment Dermatology and Skin Diseases Mycorrhizal Fungi and Plant Interactions Plant and fungal interactions Cutaneous lymphoproliferative disorders research Ocular Infections and Treatments Mycotoxins in Agriculture and Food Human auditory perception and evaluation Neutropenia and Cancer Infections Agriculture and Biological Studies Actinomycetales infections and treatment Autoimmune Bullous Skin Diseases Diverse Scientific and Economic Studies Oral Health Pathology and Treatment Dermatological diseases and infestations Probiotics and Fermented Foods

Related Journals

JO
Journal of the American Academy of Dermatology Elsevier BV
MA
Maternal and Child Nutrition WILEY
HM
HIV Medicine WILEY
BJ
British Journal of Urology WILEY
De
Dermatitis LIPPINCOTT WILLIAMS & WILKINS
SR
Skin Research and Technology WILEY